Moa Fransson
Direktor/Vorstandsmitglied bei ENZYMATICA AB
Profil
Moa Fransson is the founder of Bioflow Systems AB.
She is currently the Chief Executive Officer of Genagon Therapeutics AB and Director at Enzymatica AB.
She holds a doctorate degree from the University of Uppsala.
Aktive Positionen von Moa Fransson
| Unternehmen | Position | Beginn |
|---|---|---|
| ENZYMATICA AB | Direktor/Vorstandsmitglied | 01.05.2022 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Vorstandsvorsitzender | 01.12.2019 |
Ehemalige bekannte Positionen von Moa Fransson
| Unternehmen | Position | Ende |
|---|---|---|
| Bioflow Systems AB | Gründer | - |
Ausbildung von Moa Fransson
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENZYMATICA AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Bioflow Systems AB |
